메뉴 건너뛰기




Volumn 37, Issue 12, 2010, Pages 2267-2276

Lesion dose in differentiated thyroid carcinoma metastases after rhTSH or thyroid hormone withdrawal: 124I PET/CT dosimetric comparisons

Author keywords

124I positron emission tomography computed tomography; Differentiated thyroid carcinoma; Lesion dose per administered activity; Metastases; Recombinant human TSH; Thyroid hormone withdrawal

Indexed keywords

IODINE 124; IODINE 131; RECOMBINANT THYROTROPIN; THYROID HORMONE;

EID: 78649764974     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-010-1565-3     Document Type: Article
Times cited : (59)

References (42)
  • 3
    • 33847190355 scopus 로고    scopus 로고
    • Defects in iodide metabolism in thyroid cancer and implications for the follow-up and treatment of patients
    • 1:CAS:528:DC%2BD2sXjt1Smu70%3D 10.1038/ncpendmet0449 17315034
    • M Schlumberger L Lacroix D Russo S Filetti JM Bidart 2007 Defects in iodide metabolism in thyroid cancer and implications for the follow-up and treatment of patients Nat Clin Pract Endocrinol Metab 3 260 269 1:CAS:528:DC%2BD2sXjt1Smu70%3D 10.1038/ncpendmet0449 17315034
    • (2007) Nat Clin Pract Endocrinol Metab , vol.3 , pp. 260-269
    • Schlumberger, M.1    Lacroix, L.2    Russo, D.3    Filetti, S.4    Bidart, J.M.5
  • 4
    • 27944469859 scopus 로고    scopus 로고
    • Thyroid hormone withdrawal in patients with differentiated thyroid carcinoma: A one hundred thirty-patient pilot survey on consequences of hypothyroidism and a pharmacoeconomic comparison to recombinant thyrotropin administration
    • DOI 10.1089/thy.2005.15.1147
    • M Luster R Felbinger M Dietlein C Reiners 2005 Thyroid hormone withdrawal in patients with differentiated thyroid carcinoma: a one hundred thirty-patient pilot survey on consequences of hypothyroidism and a pharmacoeconomic comparison to recombinant thyrotropin administration Thyroid 15 1147 1155 1:CAS:528:DC%2BD2MXhtF2isLrN 10.1089/thy.2005.15.1147 16279848 (Pubitemid 41720721)
    • (2005) Thyroid , vol.15 , Issue.10 , pp. 1147-1155
    • Luster, M.1    Felbinger, R.2    Dietlein, M.3    Reiners, C.4
  • 6
    • 34248998448 scopus 로고    scopus 로고
    • Sick leave for follow-up control in thyroid cancer patients: Comparison between stimulation with Thyrogen and thyroid hormone withdrawal
    • DOI 10.1530/EJE-06-0724
    • I Borget C Corone M Nocaudie M Allyn S Iacobelli M Schlumberger, et al. 2007 Sick leave for follow-up control in thyroid cancer patients: comparison between stimulation with Thyrogen and thyroid hormone withdrawal Eur J Endocrinol 156 531 538 1:CAS:528:DC%2BD2sXls1ynsLc%3D 10.1530/EJE-06-0724 17468188 (Pubitemid 46796519)
    • (2007) European Journal of Endocrinology , vol.156 , Issue.5 , pp. 531-538
    • Borget, I.1    Corone, C.2    Nocaudie, M.3    Allyn, M.4    Iacobelli, S.5    Schlumberger, M.6    De Pouvourville, G.7
  • 7
    • 66949116318 scopus 로고    scopus 로고
    • Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): A randomized controlled study
    • 10.1111/j.1365-2265.2008.03424.x
    • D Taïeb F Sebag M Cherenko K Baumstarck-Barrau C Fortanier B Farman-Ara, et al. 2009 Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study Clin Endocrinol (Oxf) 71 115 123 10.1111/j.1365-2265.2008.03424.x
    • (2009) Clin Endocrinol (Oxf) , vol.71 , pp. 115-123
    • Taïeb, D.1    Sebag, F.2    Cherenko, M.3    Baumstarck-Barrau, K.4    Fortanier, C.5    Farman-Ara, B.6
  • 8
    • 33847720753 scopus 로고    scopus 로고
    • Short-term hypothyroidism after levothyroxine-withdrawal in patients with differentiated thyroid cancer: Clinical and quality of life consequences
    • DOI 10.1530/eje.1.02310
    • LH Duntas B Biondi 2007 Short-term hypothyroidism after Levothyroxine-withdrawal in patients with differentiated thyroid cancer: clinical and quality of life consequences Eur J Endocrinol 156 13 19 1:CAS:528:DC%2BD2sXntlyqtb4%3D 10.1530/eje.1.02310 17218721 (Pubitemid 46553899)
    • (2007) European Journal of Endocrinology , vol.156 , Issue.1 , pp. 13-19
    • Duntas, L.H.1    Biondi, B.2
  • 9
    • 0033341953 scopus 로고    scopus 로고
    • A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer
    • 1:CAS:528:DyaK1MXntlOqt74%3D 10.1210/jc.84.11.3877 10566623
    • BR Haugen F Pacini C Reiners M Schlumberger PW Ladenson SI Sherman, et al. 1999 A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer J Clin Endocrinol Metab 84 3877 3885 1:CAS:528:DyaK1MXntlOqt74%3D 10.1210/jc.84.11.3877 10566623
    • (1999) J Clin Endocrinol Metab , vol.84 , pp. 3877-3885
    • Haugen, B.R.1    Pacini, F.2    Reiners, C.3    Schlumberger, M.4    Ladenson, P.W.5    Sherman, S.I.6
  • 11
    • 16444375322 scopus 로고    scopus 로고
    • rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: A comprehensive review
    • DOI 10.1677/erc.1.00830
    • M Luster F Lippi B Jarzab P Perros M Lassmann C Reiners, et al. 2005 rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review Endocr Relat Cancer 12 49 64 1:CAS:528:DC%2BD2MXjsV2lsLg%3D 10.1677/erc.1.00830 15788638 (Pubitemid 40477087)
    • (2005) Endocrine-Related Cancer , vol.12 , Issue.1 , pp. 49-64
    • Luster, M.1    Lippi, F.2    Jarzab, B.3    Perros, P.4    Lassmann, M.5    Reiners, C.6    Pacini, F.7
  • 12
    • 33845233817 scopus 로고    scopus 로고
    • Recombinant human thyrotropin-assisted radioiodine therapy for patients with metastatic thyroid cancer who could not elevate endogenous thyrotropin or be withdrawn from thyroxine
    • DOI 10.1089/thy.2006.16.1121
    • RJ Robbins A Driedger J Magner U.S. and Canadian Thyrogen Compassionate Use Program Investigator Group 2006 Recombinant human thyrotropin-assisted radioiodine therapy for patients with metastatic thyroid cancer who could not elevate endogenous thyrotropin or be withdrawn from thyroxine Thyroid 16 1121 1130 1:CAS:528:DC%2BD28Xht1CgtbvI 10.1089/thy.2006.16.1121 17123339 (Pubitemid 44864487)
    • (2006) Thyroid , vol.16 , Issue.11 , pp. 1121-1130
    • Robbins, R.J.1    Driedger, A.2    Magner, J.3
  • 13
    • 0034328026 scopus 로고    scopus 로고
    • Compassionate use of recombinant human thyrotropin to facilitate radioiodine therapy: Case report and review of literature
    • 1:STN:280:DC%2BD3M7gvVKgsg%3D%3D 11155220
    • RJ Robbins E Voelker W Wang HA Macapinlac SM Larson 2000 Compassionate use of recombinant human thyrotropin to facilitate radioiodine therapy: case report and review of literature Endocr Pract 6 460 464 1:STN:280: DC%2BD3M7gvVKgsg%3D%3D 11155220
    • (2000) Endocr Pract , vol.6 , pp. 460-464
    • Robbins, R.J.1    Voelker, E.2    Wang, W.3    MacApinlac, H.A.4    Larson, S.M.5
  • 15
    • 34250320635 scopus 로고    scopus 로고
    • Lung dosimetry for radioiodine treatment planning in the case of diffuse lung metastases
    • 1:CAS:528:DC%2BD2sXksFKgsQ%3D%3D 17138741
    • H Song B He A Prideaux Y Du E Frey W Kasecamp, et al. 2006 Lung dosimetry for radioiodine treatment planning in the case of diffuse lung metastases J Nucl Med 47 1985 1994 1:CAS:528:DC%2BD2sXksFKgsQ%3D%3D 17138741
    • (2006) J Nucl Med , vol.47 , pp. 1985-1994
    • Song, H.1    He, B.2    Prideaux, A.3    Du, Y.4    Frey, E.5    Kasecamp, W.6
  • 16
    • 0038207951 scopus 로고    scopus 로고
    • Tumour dosimetry and response in patients with metastatic differentiated thyroid cancer using recombinant human thyrotropin before radioiodine therapy
    • 10.1007/s00259-002-1076-y 12634964
    • B de Keizer B Brans A Hoekstra PM Zelissen HP Koppeschaar CJ Lips, et al. 2003 Tumour dosimetry and response in patients with metastatic differentiated thyroid cancer using recombinant human thyrotropin before radioiodine therapy Eur J Nucl Med Mol Imaging 30 367 373 10.1007/s00259-002-1076-y 12634964
    • (2003) Eur J Nucl Med Mol Imaging , vol.30 , pp. 367-373
    • De Keizer, B.1    Brans, B.2    Hoekstra, A.3    Zelissen, P.M.4    Koppeschaar, H.P.5    Lips, C.J.6
  • 17
    • 33748794776 scopus 로고    scopus 로고
    • Comparison of iodine uptake in tumour and nontumour tissue under thyroid hormone deprivation and with recombinant human thyrotropin in thyroid cancer patients
    • DOI 10.1111/j.1365-2265.2006.02626.x
    • C Pötzi A Moameni G Karanikas J Preitfellner A Becherer C Pirich, et al. 2006 Comparison of iodine uptake in tumour and nontumour tissue under thyroid hormone deprivation and with recombinant human thyrotropin in thyroid cancer patients Clin Endocrinol (Oxf) 65 519 523 10.1111/j.1365-2265.2006.02626. x (Pubitemid 44414277)
    • (2006) Clinical Endocrinology , vol.65 , Issue.4 , pp. 519-523
    • Potzi, C.1    Moameni, A.2    Karanikas, G.3    Preitfellner, J.4    Becherer, A.5    Pirich, C.6    Dudczak, R.7
  • 18
    • 0002727966 scopus 로고    scopus 로고
    • Iodine kinetics during I-131 scanning in patients with thyroid cancer: Comparison of studies with recombinant human TSH (rhTSH) vs. hypothyroidism [abstract 49]
    • S-G Park JC Reynolds F Brucker-Davis M Whatley K McEllin D Maxted, et al. 1996 Iodine kinetics during I-131 scanning in patients with thyroid cancer: comparison of studies with recombinant human TSH (rhTSH) vs. hypothyroidism [abstract 49] J Nucl Med 37 15P
    • (1996) J Nucl Med , vol.37
    • Park, S.-G.1    Reynolds, J.C.2    Brucker-Davis, F.3    Whatley, M.4    McEllin, K.5    Maxted, D.6
  • 20
    • 34548421107 scopus 로고    scopus 로고
    • 124I-PET dosimetry in advanced differentiated thyroid cancer: Therapeutic impact
    • 1:CAS:528:DC%2BD2sXhtFaht7rK 17690789
    • L Freudenberg W Jentzen R Görges T Petrich RJ Marlowe J Knust, et al. 2007 124I-PET dosimetry in advanced differentiated thyroid cancer: therapeutic impact Nuklearmedizin 46 121 128 1:CAS:528:DC%2BD2sXhtFaht7rK 17690789
    • (2007) Nuklearmedizin , vol.46 , pp. 121-128
    • Freudenberg, L.1    Jentzen, W.2    Görges, R.3    Petrich, T.4    Marlowe, R.J.5    Knust, J.6
  • 21
    • 0038360113 scopus 로고    scopus 로고
    • I. Fleming J.S. Cooper D.E. Henson R.V.P. Hutter B.J. Kennedy (eds). 5 Lippincott-Raven Philadelphia
    • Fleming I, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, editors. AJCC cancer staging manual. 5th ed. Philadelphia: Lippincott-Raven; 1997.
    • (1997) AJCC Cancer Staging Manual
  • 22
    • 34548388758 scopus 로고    scopus 로고
    • 124I positron emission tomographic dosimetry and positron emission tomography/computed tomography imaging in differentiated thyroid cancer
    • H. Biersack F. Grunwald (eds). 2 Springer Berlin
    • Freudenberg L, Bockisch A, Jentzen W. 124I positron emission tomographic dosimetry and positron emission tomography/computed tomography imaging in differentiated thyroid cancer. In: Biersack H, Grunwald F, editors. Thyroid cancer. 2nd ed. Berlin: Springer; 2005.
    • (2005) Thyroid Cancer
    • Freudenberg, L.1    Bockisch, A.2    Jentzen, W.3
  • 23
    • 0030055645 scopus 로고    scopus 로고
    • 124I
    • DOI 10.1007/BF02163571
    • R Weinreich EJ Knust 1996 Quality assurance of iodine-124 produced via the nuclear reaction 124Te(d, 2n)124I J Radioanal Nucl Chem 213 253 261 1:CAS:528:DyaK28XltVSksrY%3D 10.1007/BF02163571 (Pubitemid 26256973)
    • (1996) Journal of Radioanalytical and Nuclear Chemistry , vol.213 , Issue.4 , pp. 253-261
    • Weinreich, R.1    Knust, E.J.2
  • 24
    • 0033622147 scopus 로고    scopus 로고
    • Preparation of 124I solutions after thermodistillation of irradiated 124TeO2 targets
    • 1:CAS:528:DC%2BD3cXhtlCju7w%3D 10.1016/S0969-8043(99)00127-X 10697724
    • EJ Knust K Dutschka R Weinreich 2000 Preparation of 124I solutions after thermodistillation of irradiated 124TeO2 targets Appl Radiat Isot 52 181 184 1:CAS:528:DC%2BD3cXhtlCju7w%3D 10.1016/S0969-8043(99)00127-X 10697724
    • (2000) Appl Radiat Isot , vol.52 , pp. 181-184
    • Knust, E.J.1    Dutschka, K.2    Weinreich, R.3
  • 25
    • 44849105514 scopus 로고    scopus 로고
    • 124I PET dosimetry protocol for radioiodine therapy of differentiated thyroid cancer
    • DOI 10.2967/jnumed.107.047159
    • W Jentzen L Freudenberg EG Eising W Sonnenschein J Knust A Bockisch 2008 Optimized 124I PET dosimetry protocol for radioiodine therapy of differentiated thyroid cancer J Nucl Med 49 1017 1023 10.2967/jnumed.107.047159 18483099 (Pubitemid 351793444)
    • (2008) Journal of Nuclear Medicine , vol.49 , Issue.6 , pp. 1017-1023
    • Jentzen, W.1    Freudenberg, L.2    Eising, E.G.3    Sonnenschein, W.4    Knust, J.5    Bockisch, A.6
  • 27
    • 0032899681 scopus 로고    scopus 로고
    • Thyroid cancer dosimetry using clearance fitting
    • 1:STN:280:DyaK1M7jtFOltQ%3D%3D 9935068
    • EE Furhang SM Larson P Buranapong JL Humm 1999 Thyroid cancer dosimetry using clearance fitting J Nucl Med 40 131 136 1:STN:280:DyaK1M7jtFOltQ%3D%3D 9935068
    • (1999) J Nucl Med , vol.40 , pp. 131-136
    • Furhang, E.E.1    Larson, S.M.2    Buranapong, P.3    Humm, J.L.4
  • 29
    • 33847296687 scopus 로고    scopus 로고
    • Segmentation of PET volumes by iterative image thresholding
    • 1:CAS:528:DC%2BD2sXhvFKmtr4%3D 17204706
    • W Jentzen L Freudenberg EG Eising M Heinze W Brandau A Bockisch 2007 Segmentation of PET volumes by iterative image thresholding J Nucl Med 48 108 114 1:CAS:528:DC%2BD2sXhvFKmtr4%3D 17204706
    • (2007) J Nucl Med , vol.48 , pp. 108-114
    • Jentzen, W.1    Freudenberg, L.2    Eising, E.G.3    Heinze, M.4    Brandau, W.5    Bockisch, A.6
  • 33
    • 70449373427 scopus 로고    scopus 로고
    • Area under the curve of TSH after levothyroxine withdrawal versus administration of recombinant human TSH (rhTSH): Possible implications for tumor growth
    • 19893921
    • PW Rosário DS Salles S Purisch 2009 Area under the curve of TSH after levothyroxine withdrawal versus administration of recombinant human TSH (rhTSH): possible implications for tumor growth Arq Bras Endocrinol Metabol 53 767 770 19893921
    • (2009) Arq Bras Endocrinol Metabol , vol.53 , pp. 767-770
    • Rosário, P.W.1    Salles, D.S.2    Purisch, S.3
  • 34
    • 77954866328 scopus 로고    scopus 로고
    • Thyroid remnant dose: 124I-PET/CT dosimetric comparison of rhTSH versus thyroid hormone withholding before radioiodine remnant ablation in differentiated thyroid cancer
    • 1:CAS:528:DC%2BC3cXhtVeisL%2FM 10.1055/s-0029-1225350 19856257
    • LS Freudenberg C Frömke T Petrich RJ Marlowe WW Koska W Brandau, et al. 2010 Thyroid remnant dose: 124I-PET/CT dosimetric comparison of rhTSH versus thyroid hormone withholding before radioiodine remnant ablation in differentiated thyroid cancer Exp Clin Endocrinol Diabetes 118 393 399 1:CAS:528:DC%2BC3cXhtVeisL%2FM 10.1055/s-0029-1225350 19856257
    • (2010) Exp Clin Endocrinol Diabetes , vol.118 , pp. 393-399
    • Freudenberg, L.S.1    Frömke, C.2    Petrich, T.3    Marlowe, R.J.4    Koska, W.W.5    Brandau, W.6
  • 35
    • 0036841049 scopus 로고    scopus 로고
    • A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation
    • 1:CAS:528:DC%2BD38XptV2mt7k%3D 12411552
    • RJ Robbins SM Larson N Sinha A Shaha C Divgi KS Pentlow, et al. 2002 A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation J Nucl Med 43 1482 1488 1:CAS:528:DC%2BD38XptV2mt7k%3D 12411552
    • (2002) J Nucl Med , vol.43 , pp. 1482-1488
    • Robbins, R.J.1    Larson, S.M.2    Sinha, N.3    Shaha, A.4    Divgi, C.5    Pentlow, K.S.6
  • 36
    • 33748114927 scopus 로고    scopus 로고
    • Recombinant human thyroid-stimulating hormone is effective for radioiodine ablation of post-surgical thyroid remnants
    • DOI 10.1097/00006231-200608000-00005, PII 0000623120060800000005
    • D Barbaro G Boni G Meucci U Simi P Lapi P Orsini, et al. 2006 Recombinant human thyroid-stimulating hormone is effective for radioiodine ablation of post-surgical thyroid remnants Nucl Med Commun 27 627 632 1:CAS:528: DC%2BD28Xms1ykt7k%3D 10.1097/00006231-200608000-00005 16829763 (Pubitemid 44305303)
    • (2006) Nuclear Medicine Communications , vol.27 , Issue.8 , pp. 627-632
    • Barbaro, D.1    Boni, G.2    Meucci, G.3    Simi, U.4    Lapi, P.5    Orsini, P.6    Pasquini, C.7    Turco, A.8    Mariani, G.9
  • 37
    • 57349134887 scopus 로고    scopus 로고
    • Preparation with recombinant human thyroid-stimulating hormone for thyroid remnant ablation with 131I is associated with lowered radiotoxicity
    • 10.2967/jnumed.108.050591 18927337
    • PW Rosário MA Borges S Purisch 2008 Preparation with recombinant human thyroid-stimulating hormone for thyroid remnant ablation with 131I is associated with lowered radiotoxicity J Nucl Med 49 1776 1782 10.2967/jnumed.108.050591 18927337
    • (2008) J Nucl Med , vol.49 , pp. 1776-1782
    • Rosário, P.W.1    Borges, M.A.2    Purisch, S.3
  • 38
    • 44149083802 scopus 로고    scopus 로고
    • Recombinant human TSH-assisted radioactive iodine remnant ablation achieves short-term clinical recurrence rates similar to those of traditional thyroid hormone withdrawal
    • DOI 10.2967/jnumed.107.049072
    • RM Tuttle M Brokhin G Omry AJ Martorella SM Larson RK Grewal, et al. 2008 Recombinant human TSH-assisted radioactive iodine remnant ablation achieves short-term clinical recurrence rates similar to those of traditional thyroid hormone withdrawal J Nucl Med 49 764 770 10.2967/jnumed.107.049072 18413378 (Pubitemid 351717542)
    • (2008) Journal of Nuclear Medicine , vol.49 , Issue.5 , pp. 764-770
    • Tuttle, R.M.1    Brokhin, M.2    Omry, G.3    Martorella, A.J.4    Larson, S.M.5    Grewal, R.K.6    Fleisher, M.7    Robbins, R.J.8
  • 39
    • 62649094564 scopus 로고    scopus 로고
    • Low-activity (2.0 GBq; 54 mCi) radioiodine post-surgical remnant ablation in thyroid cancer: Comparison between hormone withdrawal and use of rhTSH in low-risk patients
    • 1:CAS:528:DC%2BD1MXhsVOhsbvK 10.1530/EJE-08-0669 19074463
    • M Chianelli V Todino FM Graziano C Panunzi D Pace R Guglielmi, et al. 2009 Low-activity (2.0 GBq; 54 mCi) radioiodine post-surgical remnant ablation in thyroid cancer: comparison between hormone withdrawal and use of rhTSH in low-risk patients Eur J Endocrinol 160 431 436 1:CAS:528:DC%2BD1MXhsVOhsbvK 10.1530/EJE-08-0669 19074463
    • (2009) Eur J Endocrinol , vol.160 , pp. 431-436
    • Chianelli, M.1    Todino, V.2    Graziano, F.M.3    Panunzi, C.4    Pace, D.5    Guglielmi, R.6
  • 40
    • 0347134611 scopus 로고    scopus 로고
    • Iodine excretion during stimulation with rhTSH in differentiated thyroid carcinoma
    • 14668956
    • M Löffler M Weckesser C Franzius P Kies O Schober 2003 Iodine excretion during stimulation with rhTSH in differentiated thyroid carcinoma Nuklearmedizin 42 240 243 14668956
    • (2003) Nuklearmedizin , vol.42 , pp. 240-243
    • Löffler, M.1    Weckesser, M.2    Franzius, C.3    Kies, P.4    Schober, O.5
  • 41
    • 0036271745 scopus 로고    scopus 로고
    • Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET
    • 1:CAS:528:DC%2BD38XlvVWnu7k%3D 10.1007/s00259-002-0775-8 12029549
    • SM Eschmann G Reischl K Bilger J Kupferschläger MH Thelen BM Dohmen, et al. 2002 Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET Eur J Nucl Med Mol Imaging 29 760 767 1:CAS:528:DC%2BD38XlvVWnu7k%3D 10.1007/s00259-002-0775-8 12029549
    • (2002) Eur J Nucl Med Mol Imaging , vol.29 , pp. 760-767
    • Eschmann, S.M.1    Reischl, G.2    Bilger, K.3    Kupferschläger, J.4    Thelen, M.H.5    Dohmen, B.M.6
  • 42
    • 4544236386 scopus 로고    scopus 로고
    • Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software
    • 1:CAS:528:DC%2BD2cXnsFSmu70%3D 15299063
    • G Sgouros KS Kolbert A Sheikh KS Pentlow EF Mun A Barth, et al. 2004 Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software J Nucl Med 45 1366 1372 1:CAS:528:DC%2BD2cXnsFSmu70%3D 15299063
    • (2004) J Nucl Med , vol.45 , pp. 1366-1372
    • Sgouros, G.1    Kolbert, K.S.2    Sheikh, A.3    Pentlow, K.S.4    Mun, E.F.5    Barth, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.